SEC Form 4 · accession 0001140361-17-031183
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Paulson
Director
Period of report
Aug 9, 2017
Accepted (ET)
Aug 10, 2017 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1,F2 | Aug 9, 2017 | A | 974,365 | $14.6595 | D | 20,839,035 | I | By Managed Funds |
| Common Stock, no par valueF3 | holding | — | — | — | 18,166 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
- F2These Common Stock sales are due to rebalancing of our portfolios based on asset flows and represent approximately 4.5% of the Reporting Person's Common Stock holding.
- F3Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.